Ishara Investments’s KalVista Pharmaceuticals KALV Stock Holding History

Ishara Investments’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-276,750	Closed	-$5.57M	–	48
2026 Q1	$5.57M	Buy	+276,750	New	+$4.46M	5.27%	5

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ishara Investments's KALV Position: Q2 2026 in Review

Ishara Investments sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 276,750 shares — an estimated $5.57M sold.

Ishara Investments first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $5.57M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Ishara Investments reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Ishara Investments sold 276,750 KalVista Pharmaceuticals shares in Q2 2026, an estimated $5.57M.
Ishara Investments first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Ishara Investments's KalVista Pharmaceuticals position peaked at $5.57M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.